Immunic

IMUXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$147.906 M

$10.84 +0.09%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

-$97.2M

Loss-making

Shares outstanding

13,644,467

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#284Corbus PharmaceuticalsCRBP$152.3M
#285Korro BioKRRO$152.3M
#286ImmunicIMUX$147.9M
#287NRX PharmaceuticalsNRXP$143.7M
#288Spruce BiosciencesSPRB$143.7M

What if Immunic were worth as much as…

Open the what-if tool →

Gold $30.2T

$2,215,841

Per share 204,413× higher

Bitcoin $1.74T

$127,645.52

Per share 11,775× higher

Nvidia $5.52T

$404,249.36

Per share 37,292× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for Immunic are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.